<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02772809</url>
  </required_header>
  <id_info>
    <org_study_id>819787</org_study_id>
    <nct_id>NCT02772809</nct_id>
  </id_info>
  <brief_title>Usability Testing of Affordable Haptic Robots for Stroke Therapy</brief_title>
  <acronym>Theradrive</acronym>
  <official_title>Usability Testing of Affordable Haptic Robots for Stroke Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke survivors with hemiplegia will be evaluated by rehabilitation professionals and asked&#xD;
      to perform a battery of assessments to test the viability and usability of a force-feedback&#xD;
      robot that adapts to each individual subject's performance. Subsequently, they will be asked&#xD;
      to complete post-assessment questionnaires that provide feedback to the researchers on their&#xD;
      observations and thoughts about the therapy devices.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TheraDrive is a low-cost robotic system for post-stroke upper extremity rehabilitation. The&#xD;
      system uses off-the-shelf computer gaming wheels with force feedback to help reduce motor&#xD;
      impairment and improve function in the arms of stroke survivors. Preliminary results from&#xD;
      various studies have shown that the original TheraDrive system lacked a robust mechanical&#xD;
      linkage which could withstand the forces exerted by patients, lacked a patient-specific&#xD;
      adaptive controller to deliver personalized therapy, and was not capable of delivering&#xD;
      effective therapy to severely low-functioning patients. A new low-cost, high-force haptic&#xD;
      robot with a single degree of freedom has been developed to address these concerns. This&#xD;
      study has two purposes: first, to test the viability and usability of the new robot system&#xD;
      alongside the original TheraDrive system; and second, to test if low-functioning patients&#xD;
      benefit, and if so how much, from using force-feedback therapy as opposed to devices with&#xD;
      zero impedance. This will be done by recruiting approximately 36 human subjects. Exercises&#xD;
      will be performed by study subjects and an adaptive controller will monitor patient&#xD;
      performance to ensure that exercises are difficult but doable, which is important for&#xD;
      maintaining patient motivation. It is hypothesized that not only will the new system be&#xD;
      viable, but that it will provide better robot-assisted therapy to a large variety of&#xD;
      patients, especially low-functioning stroke survivors with hemiplegia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The robot was no longer available to the study.&#xD;
  </why_stopped>
  <start_date type="Actual">March 2014</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl Meyer</measure>
    <time_frame>At 0 weeks</time_frame>
    <description>The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Box and Blocks</measure>
    <time_frame>At Session 0. Pre-intervention</time_frame>
    <description>Measures ADL Function. Completed reach and grasp activities. Reached for 1 inch cube and placed with impaired arm. More blocks indicate higher function. Less blocks lower function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tracking Accuracy</measure>
    <time_frame>At Session 0</time_frame>
    <description>Tracking accuracy is measured using the normalized root mean square, which is a measure for error in tracking performance with respect to a desired goal. Root mean squared divided by the maximum error if person does not move. The higher the decimal the higher the error made. Lower is better performance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Grip Strength</measure>
    <time_frame>pre-intervention</time_frame>
    <description>Grip strength as measured by a dynamometer. Subjects were asked to squeeze a dynamometer with impaired arm. Higher forces mean better function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montreal Cognitive Assessment (MOCA)</measure>
    <time_frame>pre-intervention</time_frame>
    <description>A brief 30-question test that takes around 10 to 12 minutes to complete and helps assess people for impairment in cognition domains. Maximum is 30. Minimum is 0; Low is &lt;17 is severe cognitive impairment; a score 26 and higher is normal cognition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Becks Depression Scale</measure>
    <time_frame>Pre-intervention</time_frame>
    <description>Measures depression. The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1961). Maximum is 63 Total Score_______________Levels of Depression 1-10____________________These ups and downs are considered normal 11-16___________________ Mild mood disturbance 17-20___________________Borderline clinical depression 21-30___________________Moderate depression 31-40___________________Severe depression over 40__________________Extreme depression</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Stroke</condition>
  <condition>Hemiplegia</condition>
  <arm_group>
    <arm_group_label>Stroke survivors with low and moderate motor deficits</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with low and moderate motor deficits will 1) complete exercises with 2 commercial (joystick and wheel) and the Theradrive haptic robot after pre assessment 2) then experience 12 therapy sessions on the Theradrive haptic robot with Adaptive Feedback. 3) Assessments pre and post therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Haptic Robot Therapy with Games</intervention_name>
    <description>Commercial Joystick and Wheels Plus the Haptic TheraDrive Robot will be used. Haptic Theradrive is a low-cost robotic system for post-stroke upper extremity rehabilitation. The system uses off-the-shelf computer gaming wheels with force feedback to help reduce motor impairment and improve function in the arms of stroke survivors.</description>
    <arm_group_label>Stroke survivors with low and moderate motor deficits</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stroke survivors at least 18 years of age with hemiplegia.&#xD;
&#xD;
          -  The subject's stroke must have occurred at least 3 months prior to enrollment in the&#xD;
             study.&#xD;
&#xD;
          -  Low and Moderate functioning stroke survivors as measured by Fugl- Meyer&#xD;
&#xD;
          -  Not depressed&#xD;
&#xD;
          -  No more than Mild Cognitive Deficit&#xD;
&#xD;
          -  Participants must be able to sit upright for 4 hours at a time in Part A of the study;&#xD;
             and 2 hours at a time, 3 days a week, for Part B of the study.&#xD;
&#xD;
          -  The subject's stroke must have occurred at least 3 months prior to enrollment in the&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Greater than mild cognitive deficits&#xD;
&#xD;
          -  Greater than mild depression. A member of the research team will administer Beck's&#xD;
             Depression Inventory (BDI) to each study participant over the phone. If the&#xD;
             participant is found to have greater than mild depression, as measured by the BDI,&#xD;
             they will not qualify for the study.&#xD;
&#xD;
          -  Receiving rehabilitation on the upper limb.&#xD;
&#xD;
          -  Received Botox injections within the past 3 months.&#xD;
&#xD;
          -  Suffering from contractures (chronic loss of joint motion) or debilitating spasticity&#xD;
             in the upper extremity.&#xD;
&#xD;
          -  Experiencing greater than mild pain, and/or the PI determines that the participant&#xD;
             should no longer continue working with the novel therapy devices, the study will be&#xD;
             stopped.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle J Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PENN MEDICINE RITTENHOUSE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn Medicine Rittenhouse</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://doi.org/10.1177/2055668317708732</url>
    <description>Affordable stroke therapy in high-, low- and middle-income countries: From Theradrive to Rehab CARES, a compact robot gym</description>
  </link>
  <link>
    <url>https://doi.org/10.1109/ICORR.2015.7281300</url>
    <description>A computer model of the human arm: Predictive biomechanics for the theradrive rehabilitation system</description>
  </link>
  <reference>
    <citation>Ruparel R, Johnson MJ, Strachota E, McGuire J, Tchekanov G. Evaluation of the TheraDrive system for robot/computer assisted motivating rehabilitation after stroke. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:811-4. doi: 10.1109/IEMBS.2009.5332386.</citation>
    <PMID>19963475</PMID>
  </reference>
  <reference>
    <citation>Johnson MJ, Ramachandran B, Paranjape RP, Kosasih JB. Feasibility study of TheraDrive: a low-cost game-based environment for the delivery of upper arm stroke therapy. Conf Proc IEEE Eng Med Biol Soc. 2006;2006:695-8.</citation>
    <PMID>17946851</PMID>
  </reference>
  <reference>
    <citation>Theriault A, Nagurka M, Johnson MJ. Design and development of an affordable haptic robot with force-feedback and compliant actuation to improve therapy for patients with severe hemiparesis. IEEE Trans Haptics. 2014 Apr-Jun;7(2):161-74. doi: 10.1109/TOH.2013.51.</citation>
    <PMID>24968380</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <results_first_submitted>March 23, 2020</results_first_submitted>
  <results_first_submitted_qc>September 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 4, 2020</results_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>hemiplegia</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>robotics</keyword>
  <keyword>neuroplasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Hemiplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 14, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT02772809/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Stroke survivors over the age of 18 with hemiplegia, who are three months post event, and have varying levels of impairment in the upper extremities will be recruited. All use of the TheraDrive system will take place at the Rehabilitation Robotics Lab on the ﬁrst ﬂoor of Penn Rittenhouse</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Stroke Survivors With Varying Levels of Motor Impairment</title>
          <description>Stroke survivors with varying levels of motor deﬁcit impairment in their upper extremity.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>not completed some tasks</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Severe motor deficit participants were not included in this study.</population>
      <group_list>
        <group group_id="B1">
          <title>Subjects With Varying Levels of Motor Impairment</title>
          <description>Subjects with varying levels of motor impairments who are ages 18 and older.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>6 persons did not complete all of the tracking tasks so the data was excluded.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fugl Meyer</title>
        <description>The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.</description>
        <time_frame>At 0 weeks</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Stroke Survivors With Motor Impairment</title>
            <description>All subject used robot for tracking tasks</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl Meyer</title>
          <description>The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.5" spread="20.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Box and Blocks</title>
        <description>Measures ADL Function. Completed reach and grasp activities. Reached for 1 inch cube and placed with impaired arm. More blocks indicate higher function. Less blocks lower function</description>
        <time_frame>At Session 0. Pre-intervention</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects With Motor Impairment</title>
            <description>Subjects with deﬁcit ages 18 and older.</description>
          </group>
        </group_list>
        <measure>
          <title>Box and Blocks</title>
          <description>Measures ADL Function. Completed reach and grasp activities. Reached for 1 inch cube and placed with impaired arm. More blocks indicate higher function. Less blocks lower function</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units># of blocks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.11" spread="15.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tracking Accuracy</title>
        <description>Tracking accuracy is measured using the normalized root mean square, which is a measure for error in tracking performance with respect to a desired goal. Root mean squared divided by the maximum error if person does not move. The higher the decimal the higher the error made. Lower is better performance.</description>
        <time_frame>At Session 0</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Stroke Survivors With Motor Impairments</title>
            <description>All subject used robot for tracking tasks</description>
          </group>
        </group_list>
        <measure>
          <title>Tracking Accuracy</title>
          <description>Tracking accuracy is measured using the normalized root mean square, which is a measure for error in tracking performance with respect to a desired goal. Root mean squared divided by the maximum error if person does not move. The higher the decimal the higher the error made. Lower is better performance.</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units>accuracy index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Grip Strength</title>
        <description>Grip strength as measured by a dynamometer. Subjects were asked to squeeze a dynamometer with impaired arm. Higher forces mean better function</description>
        <time_frame>pre-intervention</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects With Motor Impairment</title>
            <description>Subjects completed tasks with robot and with clinical scale.</description>
          </group>
        </group_list>
        <measure>
          <title>Grip Strength</title>
          <description>Grip strength as measured by a dynamometer. Subjects were asked to squeeze a dynamometer with impaired arm. Higher forces mean better function</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.88" spread="22.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Montreal Cognitive Assessment (MOCA)</title>
        <description>A brief 30-question test that takes around 10 to 12 minutes to complete and helps assess people for impairment in cognition domains. Maximum is 30. Minimum is 0; Low is &lt;17 is severe cognitive impairment; a score 26 and higher is normal cognition.</description>
        <time_frame>pre-intervention</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects With Motor Impairments</title>
            <description>Subjects with motor impairments who are ages 18 and older.</description>
          </group>
        </group_list>
        <measure>
          <title>Montreal Cognitive Assessment (MOCA)</title>
          <description>A brief 30-question test that takes around 10 to 12 minutes to complete and helps assess people for impairment in cognition domains. Maximum is 30. Minimum is 0; Low is &lt;17 is severe cognitive impairment; a score 26 and higher is normal cognition.</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Becks Depression Scale</title>
        <description>Measures depression. The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1961). Maximum is 63 Total Score_______________Levels of Depression 1-10____________________These ups and downs are considered normal 11-16___________________ Mild mood disturbance 17-20___________________Borderline clinical depression 21-30___________________Moderate depression 31-40___________________Severe depression over 40__________________Extreme depression</description>
        <time_frame>Pre-intervention</time_frame>
        <population>6 subjects did not complete so not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Stroke Survivors With Motor Impairments</title>
            <description>All subject used robot for tracking tasks;</description>
          </group>
        </group_list>
        <measure>
          <title>Becks Depression Scale</title>
          <description>Measures depression. The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1961). Maximum is 63 Total Score_______________Levels of Depression 1-10____________________These ups and downs are considered normal 11-16___________________ Mild mood disturbance 17-20___________________Borderline clinical depression 21-30___________________Moderate depression 31-40___________________Severe depression over 40__________________Extreme depression</description>
          <population>6 subjects did not complete so not included in the analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.25" spread="5.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>40 months</time_frame>
      <desc>No adverse events were reported.</desc>
      <group_list>
        <group group_id="E1">
          <title>Haptic Robot Therapy With Games</title>
          <description>Subjects with low and moderate motor deficits will 1) complete exercises with 2 commercial (joystick and wheel) and the Theradrive haptic robot after pre assessment 2) then experience 12 therapy sessions on the Theradrive haptic robot with Adaptive Feedback. 3) Assessments pre and post therapy.&#xD;
Haptic Robot Therapy with Games: Commercial Joystick and Wheels Plus the Haptic TheraDrive Robot will be used. Haptic Theradrive is a low-cost robotic system for post-stroke upper extremity rehabilitation. The system uses off-the-shelf computer gaming wheels with force feedback to help reduce motor impairment and improve function in the arms of stroke survivors.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michelle J Johnson</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215 893-2665</phone>
      <email>johnmic@pennmedicine.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

